Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy

Background and Aim We assessed the feasibility of combined endoscopic ultrasound and computed tomography on response evaluation in patients with esophageal squamous cell carcinoma treated by definitive chemoradiotherapy, and the impact of response on prognosis. Methods Sixty patients treated by defi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology and hepatology Vol. 30; no. 3; pp. 463 - 469
Main Authors: Chang, Wei-Lun, Wang, Wen-Lun, Chung, Ta-Jung, Lin, Forn-Chia, Yen, Chia-Jui, Lai, Wu-Wei, Yang, Hsiao-Bai, Sheu, Bor-Shyang
Format: Journal Article
Language:English
Published: Australia Blackwell Publishing Ltd 01-03-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Aim We assessed the feasibility of combined endoscopic ultrasound and computed tomography on response evaluation in patients with esophageal squamous cell carcinoma treated by definitive chemoradiotherapy, and the impact of response on prognosis. Methods Sixty patients treated by definitive chemoradiotherapy were followed by miniprobe endoscopic ultrasound and computed tomography. The post‐treatment esophageal wall thickness was measured by miniprobe endoscopic ultrasound. Metastatic tumors were evaluated by computed tomography. The correlation between post‐treatment image findings and prognosis was evaluated. Results Twenty‐four patients (40%) had esophageal stricture after chemoradiotherapy, which limited complete evaluation by endoscopy. Miniprobe successfully penetrated all strictures to measure post‐treatment esophageal wall thickness. Both post‐treatment esophageal wall thickness < 8 mm measured by endoscopic ultrasound and no enlargement of metastatic tumor foci on computed tomography predicted good prognosis (P = 0.001). Combined evaluation with these two modalities improved survival prediction (P < 0.001). Patients who met the above two criteria after chemoradiotherapy had the longest survival compared with those who met only one or none of the criteria. The corresponding median survivals were > 30 months, 16.8 months and 7.1 months, respectively (P < 0.001). On multivariate analysis, treatment response is the strongest independent prognostic factor (hazard ratio 3.65, P = 0.006) regardless of baseline tumor‐node‐metastasis staging and chemoradiation regimen. Conclusions Response evaluation by miniprobe endoscopic ultrasound and computed tomography can predict the prognosis of esophageal squamous cell carcinoma patients treated by definitive chemoradiotherapy. Those who were judged as poor responder should receive additional treatment to improve outcome.
Bibliography:Department of Health - No. DOH101-TD-PB-111-TM003
National Cheng Kung University Hospital - No. NCKUH-10204004
ArticleID:JGH12683
ark:/67375/WNG-KV315CWH-L
istex:EC85A8123D45913868DFDEC7ACC2C1F417FA89B3
National Science Council - No. NSC 99-2314-B-006-045-MY2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0815-9319
1440-1746
DOI:10.1111/jgh.12683